Zydus Cadila reduces price of its vax for those above 12 yrs

Zydus Cadila has agreed to bring down the price of its COVID-19 vaccine to Rs 265 a dose following persistent negotiations by the government but a final deal is yet to be reached, sources said on......

Zydus Cadila proposes Rs 1,900 for 3 jabs of DNA-based vaccine

With talks underway between the central government and Zydus Cadila over the pricing of the COVID-19 vaccine ZyCov-D, the pharma company is learnt to have proposed a price of Rs 1,900 for its......

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

So far, no other vaccine has been approved globally for children below 12 years.Sohini Das reports.  IMAGE: A beneficiary receives a dose of the Covid-19 vaccine at a vaccination centre in......

Pharma factory gutted in fire in JK

A Pharmaceutical company was on Sunday gutted in a fire in Samba district of Jammu and Kashmir. The fire broke out in a unit of Cadila Pharma factory and later spread to other areas in Samba......

Cadila Pharma to enter skin care segment

The Ahmedabad-based Rs 550 crore (Rs 5.5 billion) Cadila Pharmaceuticals Lid has introduced its first skincare product, 'Umrela,' on Tuesday. The new launch is part if its strategy to enter the Rs......

Clinical trial deaths rise; pharma cos say not at fault

Despite courts slamming the authorities over the monitoring of clinical trials in the country, the number of deaths caused by the adverse impact of drugs in these processes has risen. Data from......

Pharma industry posts 51.5% growth in April sales

When compared to the domestic sales of April 2019, the growth is around 37 per cent. However, compared to the previous month (March), the growth is 18.4 per cent. IMAGE: Kindly note that this......

How Indian pharma bounced back from lockdown lows

From rising prescriptions to the pharma sales force back on the field with full vigour and companies finally finding their feet with the digital marketing strategies — Indian drug makers have......